Karnika Singh

Karnika Singh's research focuses on the molecular biology of cancer, particularly glioblastoma (GBM) and pancreatic cancer. A major theme is the role of the protein TRIB1 (Tribbles 1, a pseudokinase, meaning a protein that resembles an enzyme but may work differently) in helping tumor cells resist radiation and chemotherapy treatments, along with related work on cell cycle regulation, DNA damage response, and tumor suppressor pathways like p53. Some publications also touch on medical device regulation and risk management, suggesting an additional interest in translational or regulatory aspects of medicine.

Publication output has fluctuated over the last decade with no clear consistent growth, showing bursts of activity (e.g., 2020, 2024) interspersed with lower-output years, and averaging about 2 publications per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026